Wordt geladen...
Potential for Developing Purinergic Drugs for Gastrointestinal Diseases
Treatments for IBD, IBS, FD or motility disorders are not adequate, and purinergic drugs offer exciting new possibilities. GI symptoms that could be targeted for therapy include visceral pain, inflammatory pain, dysmotility, constipation and diarrhea. The focus of this review is on potential for dev...
Bewaard in:
| Gepubliceerd in: | Inflamm Bowel Dis |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4340257/ https://ncbi.nlm.nih.gov/pubmed/24859298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000000047 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|